[
1. Šimunović Filipčić I, Filipčić I. Schizophrenia and Physical Comorbidity. Psychiatr Danub. 2018 Jun;30(Suppl 4):152-157
]Search in Google Scholar
[
2. Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011;6(9):e2459710.1371/journal.pone.0024597317346721935426
]Search in Google Scholar
[
3. Salcudean A. The autolitic risk in patients with schizophrenia. Acta Medica Transilvanica. 2011;16(3):481-483.
]Search in Google Scholar
[
4. Salcudean A, Sirbu E, Muresan D, Bodo C. Particular aspects of social integration among patients with schizophrenia. Acta Marisiensis - Seria Medica. 2021;67(1): 34-38.
]Search in Google Scholar
[
5. Salcudean A, Ferencz M, Sabau D, Gherman M. Clinical evolution of patients with schizophrenia associated with addictive disorders. Acta Marisiensis - Seria Medica. 2020;66(4):152-154.
]Search in Google Scholar
[
6. Siafis S, Tzachanis D, Samara M, Papazisis G. Antipsychotic Drugs: From Receptor-binding Profiles to Metabolic Side Effects. Curr Neuropharmacol. 2018;16(8):1210-1223.10.2174/1570159X15666170630163616618774828676017
]Search in Google Scholar
[
7. Dieset I, Andreassen OA, Haukvik UK. Somatic Comorbidity in Schizophrenia: Some Possible Biological Mechanisms Across the Life Span. Schizophr Bull. 2016 Nov;42(6):1316-1319.10.1093/schbul/sbw028504952127033328
]Search in Google Scholar
[
8. Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment. 2012;2012:91619810.1155/2012/916198342045622966451
]Search in Google Scholar
[
9. Lehrer DS, Lorenz J. Anosognosia in schizophrenia: hidden in plain sight. Innov Clin Neurosci. 2014 May;11(5-6):10-7.
]Search in Google Scholar
[
10. Simonsen E, Newton-Howes G. Personality Pathology and Schizophrenia. Schizophr Bull. 2018 Oct 17;44(6):1180-118410.1093/schbul/sby053619249629688529
]Search in Google Scholar
[
11. Howell S, Yarovova E, Khwanda A, Rosen SD. Cardiovascular effects of psychotic illnesses and antipsychotic therapy. Heart (British Cardiac Society). 2019 Dec;105(24):1852-1859.10.1136/heartjnl-2017-31210731439658
]Search in Google Scholar
[
12. Farwell WR, Stump TE, Wang J, Tafesse E, L’Italien G, Tierney WM. Weight gain and new onset diabetes associated with olanzapine and risperidone. J Gen Intern Med. 2004 Dec;19(12):1200-5.10.1111/j.1525-1497.2004.40126.x149259615610330
]Search in Google Scholar
[
13. Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. J Neurochem. 2005 Dec;95(6):1597-607.10.1111/j.1471-4159.2005.03485.x16277612
]Search in Google Scholar
[
14. Reponen EJ, Tesli M, Dieset I, Steen NE, Vedal TSJ, Szabo A, et al. Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment. Front Psychiatry. 2021 May 28;12:623192.10.3389/fpsyt.2021.623192819270834122163
]Search in Google Scholar
[
15. Stoner SC. Management of serious cardiac adverse effects of antipsychotic medications. Ment Health Clin. 2018 Mar 23;7(6):246-254.10.9740/mhc.2017.11.246600773329955530
]Search in Google Scholar
[
16. Tuplin EW, Holahan MR. Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity. Curr Neuropharmacol. 2017 Nov 14;15(8):1192-1207.10.2174/1570159X15666170413115754
]Search in Google Scholar
[
17. Polcwiartek C, Sneider B, Graff C, Taylor D, Meyer J, Kanters JK, et al. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach. Psychopharmacology (Berl). 2015 Sep;232(18):3297-30810.1007/s00213-015-4024-9
]Search in Google Scholar
[
18. Mota NE, Lima MS, Soares BG. Amisulpride for schizophrenia. Cochrane Database Syst Rev. 2002;2002(2):CD001357.
]Search in Google Scholar
[
19. Wang MT, Lin CW, Tsai CL, Wang YH, Lai JH, Yeh CB, et al. Use of antipsychotics and the risk of acute respiratory failure among adults: A disease risk score-matched nested case-control study. Br J Clin Pharmacol. 2020 Nov;86(11):2204-2216.10.1111/bcp.14321
]Search in Google Scholar
[
20. Gaillard R, Ouanas A, Spadone C, Llorca PM, Lôo H, Baylé FJ. Benzodiazépines et schizophrénie, revue de la littérature [Benzodiazepines and schizophrenia, a review of the literature]. Encephale. 2006 Nov-Dec;32(6 Pt 1):1003-10. French.10.1016/S0013-7006(06)76280-7
]Search in Google Scholar
[
21. Fukai M, Hirosawa T, Takahashi T, Kaneda R, Kikuchi M, Minabe Y. Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report. Ther Adv Psychopharmacol. 2017 Mar;7(3):113-117.10.1177/2045125316681750535412828348731
]Search in Google Scholar
